2025 · 1st Quarter (Jan 1 - Mar 31)

ACADIA PHARMACEUTICALS, INC.

Filed by TIBER CREEK GROUP.

Open official filing

Source-reported fields

Filing overview

Type: 1st Quarter - Report
Posted: Apr 20, 2025
Income: $80,000.00
Expenses: Not reported
Registrant: TIBER CREEK GROUP
Client: ACADIA PHARMACEUTICALS, INC.
Filing UUID: 695be365-a13f-4d51-adda-64d7e8d58877
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to rare disease treatments, including rare disease research incentives; Issues related to H.R. 1262/S. 932 - Give Kids a Chance Act.

Literal federal measure citations: H.R. 1262, S. 932

TAX · Taxation/Internal Revenue Code

Issues related to the orphan drug tax credit.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.